Providing independent clinical excellence since 2005
Providing independent clinical excellence since 2005
Last updated: November 2026
Surrey Cardiovascular Clinic (SCVC) is a CQC-registered medical provider. Our articles are written to educate, but some of them describe tests and services that SCVC provides and charges for. Dr Edward Leatham, who writes most of them, has a financial interest in the clinic and in some of the services it uses. You are entitled to know that when you read what we publish, so it is set out in full here.
I am the founder of Surrey Cardiovascular Clinic and hold a 51% shareholding in the company. I practise there as a consultant cardiologist, and I receive dividends from the clinic in the event of profit.
SCVC offers diagnostic services, not all of which are routinely available on the NHS for screening, including:
When an article on this site discusses one of these, it is because I believe the evidence supports it, but I benefit financially when you use it at SCVC. Please weigh what you read with that in mind.
SCVC sells blood tests online at shop.scvc.co.uk and makes a margin on each one, which I benefit from as its majority shareholder. The company accounts are freely available.
Every test comes with a written specialist report, from me or a trained member of the clinic team, because a result on its own often leaves people unsure what to do next. In my experience results are often still read against older targets than those in current European and American guidelines; the report uses the current ones.
The same tests are available through your GP and from other laboratories.
SCVC offers a free pre-consultation review once a medical questionnaire is completed, so that you can get a clinician’s opinion before committing to any test.
The CT scanner business used by SCVC and by referring cardiologists is run by Virtual Cath Lab Surrey Ltd, trading as Heart Scan Direct, and hosted at SCVC. I am a director of that company and have a controlling financial interest in it. This is the most direct conflict of interest, so I should explain how it came about.
For roughly twenty years I referred my patients to other CT facilities and watched the same problems repeat: poor access, slow turnaround, inconsistent reporting and, as the technology evolved, no integration of AI-based image analysis. Eventually I decided that if a proper service did not exist, I would help to build one. The facility now offers same-day rapid-access assessment for chest pain (consultation, CT angiography, results and a management plan in a single visit) together with AI-enhanced visceral fat and inflammation analysis.
The conflict is real: I recommend imaging tests that I have a financial interest in providing. The same technology is increasingly available at other centres, and you are free to have it elsewhere.
I am the sole (100%) shareholder of Medicalspace Ltd. It does not provide medical services and is not a medical provider. It:
The tests behind CarbR (a continuous glucose monitor and HbA1c) are standard and available elsewhere. Using a continuous glucose monitor in people without diabetes is my clinical approach and is not yet part of guideline practice.
I receive no funding from any pharmaceutical company. I hold no equity in any GLP-1 manufacturer or in any diagnostic equipment manufacturer. Where our articles discuss specific drugs or devices, the discussion is based on published evidence and direct clinical experience, not a commercial relationship.
Randox is the paid laboratory supplier for the postal blood tests; I receive nothing from Randox. I have no financial interest in HeartFlow or Caristo.
Articles on the SCVC blog are for general education and are not individual medical advice. For decisions about your own health, speak to your GP or the clinician who knows you.
Where an article mentions a test or service that SCVC provides, it usually carries a short declaration of interest linking to this page. Where a test is also available on the NHS or from other providers, we say so.
Much of what we write about (ApoB testing, Lp(a) measurement, glucose profiling with a continuous monitor, FAI inflammation imaging, VAT-CT) is not yet routinely available on the NHS, and in some cases is difficult to access privately too. The services described above exist because I and a small group of colleagues built them for our patients when the standard pathways did not. I have a financial interest in them. I also have a clinical reason for believing they should exist. Both are true, and you are entitled to know about both.
Dr Edward Leatham, Consultant Cardiologist
Surrey Cardiovascular Clinic is a CQC-registered medical provider. The information on this website is for general educational purposes only and does not constitute individual medical advice.